Login
$DXR
$9.21 -$0.04 (0.43%) Close

Insider Transactions

What Daxor Corp's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 7
Sells 0 0
Total trades 1 11

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

Common stock only — 11 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Jefferies John Chief Medical Officer Aug 28 Grant / award · A +2,451 — — 26,008
Feldschuh Jonathan Adam Chief Scientific Officer Jun 23 Grant / award · A +25,000 — — 78,908
Michel Robert J Chief Financial Officer Jun 23 Grant / award · A +12,000 — — 33,050
Feldschuh Michael Richard Chief Executive Officer Jun 23 Grant / award · A +30,000 — — 243,694
Feldschuh Michael Richard Chief Executive Officer Apr 08 Open-market buy · P +1,000 $9.07 +$9.07K 213,694
Michel Robert J Chief Financial Officer Mar 31 Open-market buy · P +1,000 $9.90 +$9.9K 21,050
Jefferies John Chief Medical Officer Mar 20 Open-market buy · P +2,285 — — 23,557
Jefferies John Chief Medical Officer Mar 20 Open-market buy · P +3,656 — — 21,272
Michel Robert J Chief Financial Officer Dec 09 Open-market buy · P +3,000 — — 20,050
Feldschuh Jonathan Adam Chief Scientific Officer Dec 09 Open-market buy · P +18,000 — — 53,908
Jefferies John Chief Medical Officer Nov 12 Open-market buy · P +2,344 — — 17,616
Feldschuh Michael Richard Chief Executive Officer Apr 04 Open-market buy · P +2,063 $7.89 +$16.3K 212,694
Michel Robert J Chief Financial Officer Mar 10 Open-market buy · P +1,000 $8.00 +$8K 17,050
Feldschuh Jonathan Adam Chief Scientific Officer Dec 06 Open-market buy · P +32,000 — — 35,908
Feldschuh Michael Richard Chief Executive Officer Dec 06 Open-market buy · P +45,000 — — 207,492
Michel Robert J Chief Financial Officer Mar 27 Open-market buy · P +750 $8.70 +$6.53K 11,300
Feldschuh Michael Richard Chief Executive Office Mar 26 Open-market buy · P +1,000 $8.13 +$8.13K 210,631
Feldschuh Michael Richard Chief Executive Officer Mar 19 Open-market buy · P +647 $8.15 +$5.27K 209,631
Feldschuh Michael Richard Chief Executive Officer Mar 10 Open-market buy · P +1,492 $7.72 +$11.5K 208,984
Feuer Edward Director Mar 04 Open-market buy · P +1,000 $7.21 +$7.21K 1,000

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support